AbL Diagnostics Return On Equity vs. Book Value Per Share
ABLD Stock | 2.40 0.00 0.00% |
For AbL Diagnostics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of AbL Diagnostics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well AbL Diagnostics SA utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between AbL Diagnostics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of AbL Diagnostics SA over time as well as its relative position and ranking within its peers.
AbL |
AbL Diagnostics SA Book Value Per Share vs. Return On Equity Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining AbL Diagnostics's current stock value. Our valuation model uses many indicators to compare AbL Diagnostics value to that of its competitors to determine the firm's financial worth. AbL Diagnostics SA is number one stock in return on equity category among its peers. It also is number one stock in book value per share category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value AbL Diagnostics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for AbL Diagnostics' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.AbL Book Value Per Share vs. Return On Equity
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
AbL Diagnostics |
| = | -0.0612 |
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
AbL Diagnostics |
| = | 1.25 X |
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
AbL Book Value Per Share Comparison
AbL Diagnostics is currently under evaluation in book value per share category among its peers.
AbL Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on AbL Diagnostics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of AbL Diagnostics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the AbL Diagnostics' important profitability drivers and their relationship over time.
Use AbL Diagnostics in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AbL Diagnostics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AbL Diagnostics will appreciate offsetting losses from the drop in the long position's value.AbL Diagnostics Pair Trading
AbL Diagnostics SA Pair Trading Analysis
The ability to find closely correlated positions to AbL Diagnostics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AbL Diagnostics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AbL Diagnostics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AbL Diagnostics SA to buy it.
The correlation of AbL Diagnostics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AbL Diagnostics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AbL Diagnostics SA moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AbL Diagnostics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your AbL Diagnostics position
In addition to having AbL Diagnostics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Cars Thematic Idea Now
Cars
Domestic and international companies involved in manufacturing and serving automobiles and trucks. The Cars theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cars Theme or any other thematic opportunities.
View All Next | Launch |
Other Information on Investing in AbL Stock
To fully project AbL Diagnostics' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of AbL Diagnostics SA at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include AbL Diagnostics' income statement, its balance sheet, and the statement of cash flows.